CE · Celanese Corp - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $9.54B | $10.28B | $10.94B | $9.67B | $8.54B | $5.66B |
| Cost of Revenue | $7.59B | $7.92B | $8.34B | $7.29B | $5.86B | $4.36B |
| Gross Profit | $1.95B | $2.36B | $2.60B | $2.38B | $2.68B | $1.29B |
| R&D | $125.00M | $130.00M | $146.00M | $112.00M | $86.00M | $74.00M |
| SG&A | $899.00M | $1.03B | $1.07B | $824.00M | $633.00M | $482.00M |
| Total Operating Expenses | - | - | - | - | - | - |
| D&A | $760.00M | $801.00M | $706.00M | $462.00M | $371.00M | $350.00M |
| Operating Income | ($786.00M) | ($697.00M) | $1.69B | $1.38B | $1.95B | $664.00M |
| Interest Expense | $701.00M | $676.00M | $720.00M | $405.00M | $91.00M | $109.00M |
| Income Tax | ($90.00M) | $510.00M | ($790.00M) | ($489.00M) | $330.00M | $247.00M |
| Net Income | ($1.17B) | ($1.52B) | $1.96B | $1.89B | $1.89B | $1.99B |
| EPS - Basic | ($10.64) | ($13.93) | $18.01 | $17.48 | $16.99 | $16.85 |
| EPS - Diluted | ($10.64) | ($13.93) | $17.92 | $17.34 | $16.86 | $16.75 |
Balance Sheet
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.26B | $962.00M | $1.80B | $1.51B | $536.00M | $955.00M |
| Accounts Receivable | $922.00M | $1.12B | $1.24B | $1.38B | $1.16B | $792.00M |
| Inventory | $2.22B | $2.28B | $2.36B | $2.81B | $1.52B | $978.00M |
| Accounts Payable | $1.28B | $1.23B | $1.51B | $1.52B | $1.16B | $797.00M |
| Current Assets | $5.69B | $5.14B | $6.22B | $6.61B | $3.81B | $3.76B |
| Total Assets | $21.70B | $22.86B | $26.60B | $26.27B | $11.97B | $10.91B |
| Current Liabilities | $3.68B | $3.85B | $4.07B | $4.07B | $2.50B | $1.97B |
| Long-term Debt | $12.61B | $12.53B | $13.40B | $13.95B | $3.72B | $3.67B |
| Total Liabilities | - | - | - | - | - | - |
| Stockholders' Equity | $4.05B | $5.17B | $7.09B | $5.64B | $4.19B | $3.53B |
| Retained Earnings | $9.88B | $11.10B | $12.93B | $11.27B | $9.68B | $8.09B |
Cash Flow
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.15B | $966.00M | $1.90B | $1.82B | $1.76B | $1.34B |
| Investing Cash Flow | ($349.00M) | ($470.00M) | ($134.00M) | ($11.14B) | ($1.12B) | $592.00M |
| Financing Cash Flow | ($513.00M) | ($1.31B) | ($1.46B) | $10.29B | ($1.04B) | ($1.47B) |
| CapEx | $343.00M | $435.00M | $568.00M | $543.00M | $467.00M | $364.00M |
| Free Cash Flow | $803.00M | $531.00M | $1.33B | $1.28B | $1.29B | $979.00M |
Ratios
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 20.5% | 22.9% | 23.8% | 24.6% | 31.4% | 22.9% |
| Operating margin | -8.2% | -6.8% | 15.4% | 14.2% | 22.8% | 11.7% |
| EBITDA margin | -0.3% | 1.0% | 21.9% | 19.0% | 27.1% | 17.9% |
| Net margin | -12.2% | -14.8% | 17.9% | 19.6% | 22.1% | 35.1% |
| Free cash flow margin | 8.4% | 5.2% | 12.2% | 13.2% | 15.1% | 17.3% |
| FCF / Net income | -0.69 | -0.35 | 0.68 | 0.67 | 0.68 | 0.49 |
| R&D / Revenue | 1.3% | 1.3% | 1.3% | 1.2% | 1.0% | 1.3% |
| SG&A / Revenue | 9.4% | 10.0% | 9.8% | 8.5% | 7.4% | 8.5% |
| Effective tax rate | - | - | -67.5% | -34.8% | 14.9% | 11.1% |
| Return on assets | -5.4% | -6.7% | 7.4% | 7.2% | 15.8% | 18.2% |
| Return on equity | -28.8% | -29.4% | 27.6% | 33.6% | 45.1% | 56.3% |
| Return on invested capital | -3.7% | -3.1% | 8.2% | 7.0% | 20.9% | 8.2% |
| Liquidity | ||||||
| Current ratio | 1.55 | 1.34 | 1.53 | 1.63 | 1.52 | 1.91 |
| Quick ratio | 0.94 | 0.74 | 0.95 | 0.93 | 0.91 | 1.41 |
| Cash ratio | 0.34 | 0.25 | 0.44 | 0.37 | 0.21 | 0.48 |
| Leverage | ||||||
| Debt / Equity | 3.12 | 2.42 | 1.89 | 2.48 | 0.89 | 1.04 |
| Debt / Assets | 0.58 | 0.55 | 0.50 | 0.53 | 0.31 | 0.34 |
| Debt / EBITDA | - | 120.45 | 5.60 | 7.58 | 1.61 | 3.62 |
| Interest coverage | -1.1x | -1.0x | 2.3x | 3.4x | 21.4x | 6.1x |
| Equity multiplier | 5.36 | 4.42 | 3.75 | 4.66 | 2.86 | 3.09 |
| Liabilities / Assets | - | - | - | - | - | - |
| Efficiency | ||||||
| Asset turnover | 0.44 | 0.45 | 0.41 | 0.37 | 0.71 | 0.52 |
| Inventory turnover | 3.42 | 3.47 | 3.54 | 2.60 | 3.84 | 4.46 |
| Days sales outstanding | 35d | 40d | 41d | 52d | 50d | 51d |
| Days inventory outstanding | 107d | 105d | 103d | 141d | 95d | 82d |
| Days payable outstanding | 61d | 57d | 66d | 76d | 72d | 67d |
| Cash conversion cycle | 81d | 88d | 79d | 117d | 72d | 66d |
| Valuation | ||||||
| P / E | - | - | 8.7x | 5.9x | 10.0x | 7.8x |
| P / B | 1.1x | 1.5x | 2.4x | 2.0x | 4.5x | 4.4x |
| P / S | 0.5x | 0.7x | 1.6x | 1.2x | 2.2x | 2.7x |
| EV / EBITDA | - | 183.9x | 11.9x | 12.8x | 9.5x | 17.9x |
| Growth | ||||||
| Revenue growth (YoY) | -7.2% | -6.0% | 13.1% | 13.3% | 51.0% | -10.2% |
| Revenue CAGR (3y) | -0.4% | 6.4% | 24.6% | 15.4% | 16.6% | -2.7% |
| Revenue CAGR (5y) | 11.0% | 10.3% | 15.2% | 9.5% | 9.6% | -0.1% |
| Gross profit growth (YoY) | -17.1% | -9.5% | 9.4% | -11.3% | 107.4% | -19.5% |
| Operating income growth (YoY) | -12.8% | - | 22.4% | -29.2% | 193.1% | -20.4% |
| Net income growth (YoY) | 23.5% | - | 3.5% | 0.2% | -4.8% | 133.0% |
| EPS growth (YoY) | 23.6% | - | 3.3% | 2.8% | 0.7% | 144.9% |
| EPS CAGR (3y) | - | - | 2.3% | 36.4% | 23.7% | 40.1% |
| EPS CAGR (5y) | - | - | 15.0% | 23.3% | 22.2% | 53.0% |
| FCF growth (YoY) | 51.2% | -60.1% | 4.3% | -1.1% | 31.8% | -9.7% |
| FCF CAGR (5y) | -3.9% | -13.3% | 1.7% | 18.9% | 14.8% | 9.2% |
| Book value growth (YoY) | -21.8% | -27.0% | 25.8% | 34.6% | 18.8% | 40.6% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Business segments
$9.62B totalEngineered Materials$5.39B · 56.0%
Acetyl Chain$4.23B · 44.0%
Geographic
$14.93B totalUS$2.57B · 17.2%
CH$2.47B · 16.5%
Asia Pacific$2.23B · 15.0%
CN$1.79B · 12.0%
EMEA$1.57B · 10.5%
North America$1.46B · 9.7%
DE$750.00M · 5.0%
SG$707.00M · 4.7%
JP$290.00M · 1.9%
MX$243.00M · 1.6%
Other Foreign Countries$212.00M · 1.4%
IN$148.00M · 1.0%
South America$129.00M · 0.9%
BR$127.00M · 0.9%
KR$127.00M · 0.9%
CA$108.00M · 0.7%
BE$2.00M · 0.0%
Stability scores
Piotroski F-score
FY 2025 · 9-point quality
5/9
Neutral
- ✗Net income positive
- ✓Operating cash flow positive
- ✓ROA improved YoY
- ✓Cash flow > net income
- ✗Long-term debt decreased
- ✓Current ratio improved
- ✓No share dilution
- ✗Gross margin improved
- ✗Asset turnover improved
Peer comparison
Same SIC group: Plastic Material, Synth Resin/Rubber, Cellulos (No Glass)
Comparing Celanese Corp against the 2 most active filers in the same SIC group.
Dividends
$0.12/share trailing 12 months · -91.8% YoY
| Ex-date | Per share |
|---|---|
| Apr 27, 2026 | $0.0300 |
| Feb 24, 2026 | $0.0300 |
| Oct 28, 2025 | $0.0300 |
| Jul 29, 2025 | $0.0300 |
| Apr 28, 2025 | $0.0300 |
| Feb 25, 2025 | $0.0300 |
| Oct 30, 2024 | $0.7000 |
| Jul 30, 2024 | $0.7000 |
| Apr 26, 2024 | $0.7000 |
| Feb 16, 2024 | $0.7000 |
| Oct 27, 2023 | $0.7000 |
| Jul 28, 2023 | $0.7000 |
| Apr 28, 2023 | $0.7000 |
| Feb 17, 2023 | $0.7000 |
| Oct 28, 2022 | $0.7000 |
| Jul 22, 2022 | $0.6800 |
| Apr 27, 2022 | $0.6800 |
| Feb 18, 2022 | $0.6800 |
| Oct 29, 2021 | $0.6800 |
| Jul 23, 2021 | $0.6800 |
| Apr 23, 2021 | $0.6800 |
| Feb 8, 2021 | $0.6800 |
| Oct 26, 2020 | $0.6200 |
| Jul 24, 2020 | $0.6200 |